Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 2,245.00
-30.00 (-1.32%)
At close: Oct 23, 2026
Remed Market Cap
Remed has a market cap or net worth of 66.8 billion as of October 23, 2026. It is the 30,027th most valuable company in the world and the 1,575th biggest in South Korea. Its market cap has decreased by 38.64% in one year.
Market Cap
66.80B
Enterprise Value
63.82B
Revenue
27.05B
Global Rank
Country Rank
#1,575 South Korea
PE Ratio
47.23
ChartMarket Cap Chart
Since August 14, 2018, Remed's market cap has decreased from 73.83B to 66.80B, a decrease of -9.52%. That is a compound annual growth rate of -1.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 66.80B | -29.60% |
| Dec 30, 2025 | 94.88B | -13.97% |
| Dec 30, 2024 | 110.30B | 10.60% |
| Dec 28, 2023 | 99.73B | 31.78% |
| Dec 29, 2022 | 75.68B | -53.48% |
| Dec 30, 2021 | 162.69B | -18.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 149.31B |
| Mezoo | 134.98B |
| Hironic | 70.34B |
| SELVAS Healthcare | 61.98B |
| DRGEM | 55.35B |
| Dynamic solution | 52.00B |
| QuantaMatrix | 45.20B |
| Genoray | 40.49B |